Jump to:
Chris Armistead joined Ropes & Gray's corporate department in 2021 and is an associate in the mergers & acquisitions group. Chris's practice focuses on representing public and private companies in mergers, acquisitions, joint ventures, divestitures and other strategic transactions. Chris also advises clients on corporate governance matters.
Experience
- Represent Nippon Steel, Japan's largest steelmaker, in its $14.1 billion pending acquisition of U.S. Steel.
- Represented Eversource Energy in the divestiture of its offshore wind energy assets, including the sale of the undeveloped portion of its offshore wind lease area and the Sunrise Wind project to Ørsted and the sale of the Revolution Wind and South Fork Wind projects to Global Infrastructure Partners.
- Represented Vapotherm, Inc. in its merger with a newly-formed entity organized and funded by an affiliate of Perceptive Advisors, LLC, a leading health care investment firm, and its Perceptive Discovery Fund.
- Represented EMCOR Group, Inc. in its acquisition of ECM Corp.
- Represented Heidelberg Materials in connection with the acquisition of The SEFA Group, Inc., the largest recycler of fly ash sold for use in concrete products in the United States.
- Represented Pfizer, Inc. in its $11.6 billion acquisition of Biohaven Pharmaceuticals.
- Represented McAfee Corp. in its $14 billion acquisition by an investor group comprised of Advent, Permira, Crosspoint Capital, Canada Pension Plan Investment Board, GIC and ADIA.